Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 4/2013

01.08.2013 | Clinical Investigation

Clinical, Laboratorial, and Urodynamic Findings of Prostatic Artery Embolization for the Treatment of Urinary Retention Related to Benign Prostatic Hyperplasia. A Prospective Single-Center Pilot Study

verfasst von: Alberto A. Antunes, Francisco C. Carnevale, Joaquim M. da Motta Leal Filho, Eduardo M. Yoshinaga, Luciana M. O. Cerri, Ronaldo H. Baroni, Antonio S. Z. Marcelino, Giovanni G. Cerri, Miguel Srougi

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study was designed to describe the clinical, laboratorial, and urodynamic findings of prostatic artery embolization (PAE) in patients with urinary retention due to benign prostatic hyperplasia (BPH).

Methods

A prospective study of 11 patients with urinary retention due to BPH was conducted. Patients underwent physical examination, prostate specific antigen (PSA) measurement, transrectal ultrasound, and magnetic resonance imaging. International prostate symptom score (IPSS), quality of life (QoL), and urodynamic testing were used to assess the outcome before and after 1 year.

Results

Clinical success was 91 % (10/11 patients) with a mean follow-up of 22.3 months (range, 12–41 months). At the first year follow-up, the mean IPSS score was 2.8 points (p = 0.04), mean QoL was 0.4 points (p = 0.001), mean PSA decreased from 10.1 to 4.3 ng/mL (p = 0.003), maximum urinary flow (Qmax) improved from 4.2 to 10.8 mL/sec (p = 0.009), and detrusor pressure (Pdet) decreased from 85.7 to 51.5 cm H2O (p = 0.007). Before PAE, Bladder Outlet Obstruction Index (BOOI) showed values >40 in 100 % of patients. After PAE, 30 % of patients were >40 (obstructed), 40 % were between 20 and 40 (undetermined), and 30 % were <20 (unobstructed). Patients with a BOOI <20 had higher PSA values at 1-day after PAE.

Conclusions

Clinical and urodynamic parameters improved significantly after PAE in patients with acute urinary retention due to BPH. Total PSA at day 1 after PAE was higher in patients with unobstructed values in pressure flow studies.
Literatur
1.
Zurück zum Zitat McVary KT (2006) BPH: epidemiology and comorbidities. Am J Manage Care 12(5 Suppl):122–128 McVary KT (2006) BPH: epidemiology and comorbidities. Am J Manage Care 12(5 Suppl):122–128
2.
Zurück zum Zitat Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ (2004) EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46:547–554PubMedCrossRef Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ (2004) EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46:547–554PubMedCrossRef
3.
Zurück zum Zitat McVary KT, Roehrborn CG, Avins AL et al (2011) Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 185(5):1793–1803PubMedCrossRef McVary KT, Roehrborn CG, Avins AL et al (2011) Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 185(5):1793–1803PubMedCrossRef
4.
Zurück zum Zitat Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP): incidence, management, and prevention. Eur Urol 50(5):969–979PubMedCrossRef Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP): incidence, management, and prevention. Eur Urol 50(5):969–979PubMedCrossRef
5.
Zurück zum Zitat Mitchell ME, Waltman AC, Athanasoulis CA, Kerr WS Jr, Dretler SP (1976) Control of massive prostatic bleeding with angiographic techniques. J Urol 115(6):692–695PubMed Mitchell ME, Waltman AC, Athanasoulis CA, Kerr WS Jr, Dretler SP (1976) Control of massive prostatic bleeding with angiographic techniques. J Urol 115(6):692–695PubMed
6.
Zurück zum Zitat Bischoff W, Goerttler U (1977) Successful intra-arterial embolization of bleeding carcinoma of the prostate. Urologe A 16:99–102PubMed Bischoff W, Goerttler U (1977) Successful intra-arterial embolization of bleeding carcinoma of the prostate. Urologe A 16:99–102PubMed
7.
Zurück zum Zitat Nadalini VF, Positano N, Bruttini GP, Medica M, Fasce L (1981) Therapeutic occlusion of the hypogastric arteries with isobutyl-2-cyanoacrylate in vesical and prostatic cancer. Radiol Med 67(1–2):61–66PubMed Nadalini VF, Positano N, Bruttini GP, Medica M, Fasce L (1981) Therapeutic occlusion of the hypogastric arteries with isobutyl-2-cyanoacrylate in vesical and prostatic cancer. Radiol Med 67(1–2):61–66PubMed
8.
Zurück zum Zitat Appleton DS, Sibley GN, Doyle PT (1988) Internal iliac artery embolisation for the control of severe bladder and prostate haemorrhage. Br J Urol 61(1):45–47PubMedCrossRef Appleton DS, Sibley GN, Doyle PT (1988) Internal iliac artery embolisation for the control of severe bladder and prostate haemorrhage. Br J Urol 61(1):45–47PubMedCrossRef
9.
Zurück zum Zitat DeMeritt JS, Elmasri FF, Esposito MP, Rosemberg GS (2000) Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol 11(6):767–770PubMedCrossRef DeMeritt JS, Elmasri FF, Esposito MP, Rosemberg GS (2000) Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol 11(6):767–770PubMedCrossRef
10.
Zurück zum Zitat Barbieri A, Simonazzi M, Marcato C et al (2002) Massive hematuria after transurethral resection of the prostate: management by intra-arterial embolization. Urol Int 69(4):318–320PubMedCrossRef Barbieri A, Simonazzi M, Marcato C et al (2002) Massive hematuria after transurethral resection of the prostate: management by intra-arterial embolization. Urol Int 69(4):318–320PubMedCrossRef
11.
Zurück zum Zitat Michel F, Dubruille T, Cercueil JP, Paparel P, Cognet F, Krause D (2002) Arterial embolization for massive hematuria following transurethral prostatectomy. J Urol 168(6):2550–2551PubMedCrossRef Michel F, Dubruille T, Cercueil JP, Paparel P, Cognet F, Krause D (2002) Arterial embolization for massive hematuria following transurethral prostatectomy. J Urol 168(6):2550–2551PubMedCrossRef
12.
Zurück zum Zitat Rastinehad AR, Caplin DM, Ost MC et al (2008) Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin. Urology 71(2):181–184PubMedCrossRef Rastinehad AR, Caplin DM, Ost MC et al (2008) Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin. Urology 71(2):181–184PubMedCrossRef
13.
Zurück zum Zitat Tan L, Venkatesh SK, Consigliere D, Heng CT (2009) Treatment of a patient with post-TURP hemorrhage using bilateral SAPE. Nat Rev Urol 6(12):680–685PubMedCrossRef Tan L, Venkatesh SK, Consigliere D, Heng CT (2009) Treatment of a patient with post-TURP hemorrhage using bilateral SAPE. Nat Rev Urol 6(12):680–685PubMedCrossRef
14.
Zurück zum Zitat Sun F, Sánchez FM, Crisóstomo V et al (2008) Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment—preliminary study in pigs. Radiology 246(3):783–789PubMedCrossRef Sun F, Sánchez FM, Crisóstomo V et al (2008) Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment—preliminary study in pigs. Radiology 246(3):783–789PubMedCrossRef
15.
Zurück zum Zitat Jeon GS, Won JH, Lee BM et al (2009) The effect of transarterial prostate embolization in hormone-induced benign prostatic hyperplasia in dogs: a pilot study. J Vasc Interv Radiol 20(3):384–390PubMedCrossRef Jeon GS, Won JH, Lee BM et al (2009) The effect of transarterial prostate embolization in hormone-induced benign prostatic hyperplasia in dogs: a pilot study. J Vasc Interv Radiol 20(3):384–390PubMedCrossRef
16.
Zurück zum Zitat Carnevale FC, Antunes AA, da Motta-Leal-Filho JM et al (2010) Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol 33(2):355–361PubMedCrossRef Carnevale FC, Antunes AA, da Motta-Leal-Filho JM et al (2010) Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol 33(2):355–361PubMedCrossRef
17.
Zurück zum Zitat Carnevale FC, da Motta-Leal-Filho JM, Antunes AA et al (2011) Midterm follow-up after prostate embolization in two patients with benign prostatic hyperplasia. Cardiovasc Intervent Radiol 34(6):1330–1333PubMedCrossRef Carnevale FC, da Motta-Leal-Filho JM, Antunes AA et al (2011) Midterm follow-up after prostate embolization in two patients with benign prostatic hyperplasia. Cardiovasc Intervent Radiol 34(6):1330–1333PubMedCrossRef
18.
Zurück zum Zitat Schäfer W, Abrams P, Liao L et al (2002) Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21:261–274PubMedCrossRef Schäfer W, Abrams P, Liao L et al (2002) Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21:261–274PubMedCrossRef
19.
Zurück zum Zitat Abrams P (1999) Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 84(1):14–15PubMedCrossRef Abrams P (1999) Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 84(1):14–15PubMedCrossRef
20.
Zurück zum Zitat Kuntz RM, Ahyai S, Lehrich K, Fayad A (2004) Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 172:1012–1016PubMedCrossRef Kuntz RM, Ahyai S, Lehrich K, Fayad A (2004) Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 172:1012–1016PubMedCrossRef
21.
Zurück zum Zitat Muzzonigro G, Milanese G, Minardi D, Yehia M, Galosi AB, Dellabella M (2004) Safety and efficacy of transurethral resection of prostate glands up to 150 mL: a prospective comparative study with 1 year of followup. J Urol 172:611–615PubMedCrossRef Muzzonigro G, Milanese G, Minardi D, Yehia M, Galosi AB, Dellabella M (2004) Safety and efficacy of transurethral resection of prostate glands up to 150 mL: a prospective comparative study with 1 year of followup. J Urol 172:611–615PubMedCrossRef
22.
Zurück zum Zitat Pisco JM, Pinheiro LC, Bilhim T, Duarte M, Mendes JR, Oliveira AG (2011) Prostatic artery embolization to treat benign prostatic hyperplasia. J Vasc Interv Radiol 22(1):11–19PubMedCrossRef Pisco JM, Pinheiro LC, Bilhim T, Duarte M, Mendes JR, Oliveira AG (2011) Prostatic artery embolization to treat benign prostatic hyperplasia. J Vasc Interv Radiol 22(1):11–19PubMedCrossRef
23.
Zurück zum Zitat Carnevale FC, da Motta-Leal-Filho JM, Antunes AA et al (2013) Quality of life and clinical symptoms improvement support prostatic artery embolization for patients with acute urinary retention due to benign prostatic hyperplasia. J Vasc Interv Radiol. doi:10.1016/j.jvir.2012.12.019 Carnevale FC, da Motta-Leal-Filho JM, Antunes AA et al (2013) Quality of life and clinical symptoms improvement support prostatic artery embolization for patients with acute urinary retention due to benign prostatic hyperplasia. J Vasc Interv Radiol. doi:10.​1016/​j.​jvir.​2012.​12.​019
24.
Zurück zum Zitat Milord RA, Kahane H, Epstein JI (2000) Infarct of the prostate gland: experience on needle biopsy specimens. Am J Surg Pathol 24(10):1378–1384PubMedCrossRef Milord RA, Kahane H, Epstein JI (2000) Infarct of the prostate gland: experience on needle biopsy specimens. Am J Surg Pathol 24(10):1378–1384PubMedCrossRef
25.
Zurück zum Zitat Cross MJ, Claesson-Welsh L (2001) FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 22:201–207PubMedCrossRef Cross MJ, Claesson-Welsh L (2001) FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 22:201–207PubMedCrossRef
26.
Zurück zum Zitat Antunes AA, de Freire G C, Aiello Filho D, Cury J, Srougi M (2006) Analysis of the risk factors for incidental carcinoma of the prostate in patients with benign prostatic hyperplasia. Clinics (São Paulo) 61(6):545–550 Antunes AA, de Freire G C, Aiello Filho D, Cury J, Srougi M (2006) Analysis of the risk factors for incidental carcinoma of the prostate in patients with benign prostatic hyperplasia. Clinics (São Paulo) 61(6):545–550
Metadaten
Titel
Clinical, Laboratorial, and Urodynamic Findings of Prostatic Artery Embolization for the Treatment of Urinary Retention Related to Benign Prostatic Hyperplasia. A Prospective Single-Center Pilot Study
verfasst von
Alberto A. Antunes
Francisco C. Carnevale
Joaquim M. da Motta Leal Filho
Eduardo M. Yoshinaga
Luciana M. O. Cerri
Ronaldo H. Baroni
Antonio S. Z. Marcelino
Giovanni G. Cerri
Miguel Srougi
Publikationsdatum
01.08.2013
Verlag
Springer New York
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 4/2013
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-013-0611-5

Weitere Artikel der Ausgabe 4/2013

CardioVascular and Interventional Radiology 4/2013 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.